Effect of Implementing Prevention Measures Through Personalized Information in Emergency Departments on Adherence to Prevention Measures (PREV-URG)
Effect of Implementing Prevention Measures Through Personalized Information in Emergency Departments on Adherence to Prevention Measures: A Multicenter, Randomized Controlled Exploratory Trial
Prevention, a cornerstone of public health, remains underutilized despite its proven effectiveness. Vaccinations, screenings, reduced consumption of toxic substances, and healthy lifestyle and dietary habits can significantly reduce morbidity and mortality. However, participation rates in France remain low compared to those of neighboring European countries, particularly with regard to cancer screenings and vaccination coverage. A lack of information, motivation, or unequal access hinders adherence to preventive measures. Some of these factors can be addressed.
Emergency departments, although rarely utilized for prevention, serve a diverse population and could serve as a strategic lever for educating the public about preventive health measures.
Personalized information, supported by a digital tool, could improve adherence to preventive measures. An interactive questionnaire was developed to tailor the information provided to patients based on their personal characteristics. The information delivered in this way would be more targeted for each patient and more likely to have a positive impact on the implementation of various preventive measures.
The purpose of this study is to determine whether a digital tool that provides personalized prevention information is more effective than general, non-personalized information in improving adherence among patients visiting the emergency department to the preventive measures recommended for them.
Studie Overzicht
Toestand
Conditie
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Christelle JADEAU
- Telefoonnummer: +332 44 71 07 81
- E-mail: cjadeau@ch-lemans.fr
Studie Contact Back-up
- Naam: Cyrielle HOUALARD, MD
- Telefoonnummer: +332 43 43 43 43
- E-mail: choualard@ch-lemans.fr
Studie Locaties
-
-
Sarthe
-
La Flèche, Sarthe, Frankrijk, 72205
- Pôle Santé Sarthe et Loir
-
Contact:
- Cyrielle HOUALARD, MD
- Telefoonnummer: +332 44 71 30 00
- E-mail: choualard@ch-lemans.fr
-
Le Mans, Sarthe, Frankrijk, 72000
- Centre Hospitalier du Mans
-
Contact:
- Cyrielle HOUALARD, MD
- Telefoonnummer: +332 43 43 43 43
- E-mail: choualard@ch-lemans.fr
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Adult patients (≥ 18 years of age)
- Patients seen in the emergency departments of Le Mans University Hospital and the PSSL
- Patients who have given their free and informed oral consent
Exclusion Criteria:
- Patients who have previously participated in the study
- Patients with limited understanding of the French language
- Patients unable to give informed consent
- Individuals not enrolled in or not eligible for a social security program
- Individuals deprived of their liberty by judicial or administrative order
- Individuals receiving involuntary psychiatric care
- Individuals subject to a legal protective measure
- Pregnant or breastfeeding patients.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Preventie
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: A - Intervention
The first "intervention" group, designated A, is exposed to personalized information via a digital educational tool based on the characteristics entered for them.
|
The intervention involves providing personalized preventive health information regarding recommended preventive measures based on age, biological sex, weight, height, bedtime and wake-up times, the presence of chronic conditions, and tobacco or alcohol use.
|
|
Experimenteel: B - Control
The second "control" group, designated B, receives non-personalized information.
Using the same digital tool, the patient receives all the preventive health information without it being tailored to the patient.
The patient therefore does not see any information specific to him or her.
|
The intervention involves providing non-personalized preventive health information.
The patient receives all the preventive health information without it being tailored to the patient.
The patient therefore does not see any information specific to him or her.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
proportion of patients who adhered to at least 25% of the preventive measures
Tijdsspanne: 6-8 weeks after the intervention.
|
The primary outcome measure is the proportion of patients who adhered to at least 25% of the preventive measures for which they were eligible, as assessed 6-8 weeks after the intervention. Adherence is defined as the completion of a preventive measure or the initiation of steps leading to its completion in the short term |
6-8 weeks after the intervention.
|
Secundaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
|---|---|
|
The proportion of patients who adhered to each of the preventive measures studied.
Tijdsspanne: 6-8 weeks after the intervention.
|
6-8 weeks after the intervention.
|
|
The proportion of preventive measures taken by the patient, relative to the measures for which the patient is eligible.
Tijdsspanne: 6-8 weeks after the intervention.
|
6-8 weeks after the intervention.
|
|
The enrollment rate for each epidemiological subgroup (age, sex, whether the patient has a primary care physician, whether the patient has a chronic condition, socioeconomic status).
Tijdsspanne: 6-8 weeks after the intervention.
|
6-8 weeks after the intervention.
|
Medewerkers en onderzoekers
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Andere studie-ID-nummers
- CHM-2025/S02/17
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .